Aurobindo Pharma arm gets U.S. FDA nod for generic of BMS’ cancer drug
Published on 24/04/2025 03:04 PM
Aurobindo Pharma’s Eugia Pharma has been approved the U.S. FDA to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb’s Sprycel